Somatization syndromes in the DSM-5

Journal title PSICOTERAPIA E SCIENZE UMANE
Author/s Piero Porcelli
Publishing Year 2014 Issue 2014/3
Language Italian Pages 22 P. 431-452 File size 115 KB
DOI 10.3280/PU2014-003004
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

This paper aims at describing diagnostic criteria for Somatic Symptom Disorders in the new DSM-5. The DSM-5 has preserved some core features of the earlier DSM versions, such as the atheoretical approach and the hierarchical rule, and has substantially changed the category of DSM-IV Somatoform Disorders by eliminating Hypochondriasis, grouping the main syndromes into two categories of Somatic Symptom Disorder and Illness Anxiety Disorder, and moving Body Dismorphic Disorder in the Obsessive- Compulsive Disorder category. This new classification has caused much criticism from the methodological as well as content perspective, highlighting the risk of over-pathologizing ordinary somatic sensations, providing psychiatric stigma to severe medical diseases, and paying more attention to Big Pharma than clinical utility. Some alternative criteria are then reported, as those included in the Psychodynamic Diagnostic Manual (PDM) and the Diagnostic Criteria for Psychosomatic Research (DCRP).

Keywords: Diagnosis, somatic symptom disorder, DSM-5, psychosomatics, somatization

  1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, D.C.: APA (trad. it. basata sulla “Versione internazionale con i codici dell’ICD-10” del 1995: DSM-IV. Manuale diagnostico e statistico dei disturbi mentali. Quarta edizione. Milano: Masson, 1995).
  2. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, D.C.: APA (trad. it.: DSM-5. Manuale diagnostico e statistico dei disturbi mentali. Quinta edizione. Milano: Raffaello Cortina, 2014).
  3. Angell M. (2011). The epidemic of mental illness: Why? The New York Review of Books, 58, 11 (23 giugno): 20-22; The illusions of psychiatry. The New York Review of Books, 58, 12 (14 luglio): 20-22 (trad. it. di entrambi gli articoli: L’epidemia di malattie mentali e le illusioni della psichiatria. Psicoterapia e Scienze Umane, 2012, XLVI, 2: 263-282. DOI: 10.3280/PU2012-002008)
  4. Barron J.W., editor (1998). Making Diagnosis Meaningful: Enhancing Evaluation and Treatment of Psychological Disorders. Washington, D.C.: American Psychological Association (trad. it.: Dare un senso alla diagnosi. Milano: Raffaello Cortina, 2005).
  5. Carta M.G., Sancassiani F., Pippia V., Bhat K.M., Sardu C. & Meloni L. (2013). Alexithymia is associated with delayed treatment seeking in acute myocardial infarction. Psychotherapy and Psychosomatics, 82, 3: 190-192. DOI: 10.1159/000341181
  6. Cornally N. & McCarthy G. (2011). Help-seeking behavior for the treatment of chronic pain. British Journal of Community Nursing, 16: 90-98.
  7. Cosgrove L. & Krimsky S. (2012). A Comparison of DSM-IV and DSM-5 panel members’ financial associations with industry: A pernicious problem persists. PLoS Medicine, 9, 3: e1001190. DOI: 10.1371/journal.pmed.1001190
  8. Cosgrove L., Krimsky S., Wheeler E.E., Kaitz J., Greenspan S.B. & Dipentima N.L. (2014). Tripartite conflicts of interest and high stakes patent extensions in the DSM-5. Psychotherapy and Psychosomatics, 83, 2: 106-113. DOI: 10.1159/000357499
  9. Dimsdale J.E., Creed F., Escobar J., Sharpe M., Wulsin L., Barsky A., Lee S., Irwin M.R. & Levenson J. (2013). Somatic Symptom Disorder: An important change in DSM. Journal of Psychosomatic Research, 75, 3: 223-228. DOI: 10.1016/j.jpsychores.2013.06.033
  10. Engel G.L. (1960). A unified concept of health and disease. Perspectives in Biology and Medicine, 3: 48-57.
  11. Engel G.L. (1968) A reconsideration of the role of conversion in somatic disease. Comprehensive Psychiatry, 9: 316-326.
  12. Engel G.L. (1970). Conversion symptoms. In: MacBryde C.M. & Blacklow R.S. , editors. Signs and symptoms. Philadelphia: Lippincott, 1970, pp. 650-669.
  13. Engel G.L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196, 4286: 129-136. DOI: 10.1126/science.847460
  14. Fava G.A., Rafanelli C. & Tomba E. (2012). The clinical process in psychiatry: A clinimetric approach. Journal of Clinical Psychiatry, 73, 2: 177-184. DOI: 10.4088/JCP.10r06444
  15. Fava G.A. & Wise T. (2007). Issues for DSM-V: Psychological factors affecting either identified or feared medical conditions: A solution for Somatoform Disorders. American Journal of Psychiatry, 164: 1002-1003. DOI: 10.1176/appi.ajp.164.7.1002
  16. First M.B. (2011). Moving beyond unexplained medical symptoms in DSM-5: Great idea, problematic execution. Psychosomatics, 52, 6: 584-585. DOI: 10.1016/j.psym.2011.05.002
  17. Frances A. (2010). DSM in philosophyland: Curiouser and curiouser. Bullettin of the Association for the Advancement of Philosophy and Psychiatry (AAPP), 17, 1: 21-25; Reprint: 17, 2: 3-7. Internet: http://alien.dowling.edu/~cperring/aapp/bulletin.htm (trad. it.: Il DSM nel paese della filosofia. aut aut, 2013, 357: 99-112).
  18. Frances A. (2011). “Psichiatria tra diagnosi e diagnosticismo. Il dibattito critico sulla preparazione del DSM-5”. Incontro con Allen Frances organizzato da Psicoterapia e Scienze Umane all’interno della “Settimana della Salute Mentale” dell’AUSL di Bologna. Con interventi di Giovanni de Girolamo, Angelo Fioritti, Paolo Migone e Giovanni Neri. Vedi il sito Internet http://www.psicoterapiaescienzeumane.it/Frances_22-10-11.htm. YouTube: https:// www.youtube.com/watch?v=bnYluMWN6dI.
  19. Frances A. (2012). Mislabeling medical illness as mental disorder. The eleventh DSM 5 mistake needs an eleventh hour correction. Psychology Today, Dec. 8, 2012: http://www.psychologytoday.com/blog/dsm5-in-distress/201212/mislabeling-medicalillness-mental-disorder.
  20. Frances A. (2013a). Saving Normal: An Insider’s Revolt against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life. New York: William Morrow (trad. it.: Primo, non curare chi è normale. Contro l’invenzione delle malattie. Torino: Bollati Boringhieri, 2013).
  21. Frances A. (2013b). Essentials of Psychiatric Diagnosis. New York: Guilford (trad. it.: La diagnosi in psichiatria. Ripensare il DSM-5. Prefazione all’edizione italiana di Franco Del Corno, Vittorio Lingiardi e Paolo Migone. Milano: Raffaello Cortina, 2014).
  22. Gornall J. (2013). DSM-5: A fatal diagnosis? British Medical Journal, 346, f3256. DOI: 10.1136/bmj.f3256
  23. Guidi J., Rafanelli C., Roncuzzi R., Sirri L. & Fava G.A. (2013). Assessing psychological factors affecting medical conditions: comparison between different proposals. General Hospital Psychiatry, 35, 2: 141-146. DOI: 10.1016/j.genhosppsych.2012.09.007
  24. Häuser W. & Wolfe F. (2013). The Somatic Symptom Disorder in DSM 5 risks mislabeling people with major medical diseases as mentally ill. Journal of Psychosomatic Research, 75, 6: 586-587. DOI: 10.1016/j.jpsychores.2013.09.005
  25. Jasper F., Hiller W., Rist F., Bailer J. & Witthöft M. (2012). Somatic symptom reporting has a dimensional latent structure: results from taxometric analyses. Journal of Abnormal Psychology, 121, 3: 725-738. DOI: 10.1037/a0028407
  26. Jones M.P., Chey W.D., Singh S., Gong H., Shringarpure R., Hoe N. Chuang E. & Talley N.J. (2014). A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Alimentary Pharmacology and Therapeutics, 39, 4: 426-437. DOI: 10.1111/apt.12608
  27. Kato K., Sullivan P.F. & Pedersen N.L. (2010). Latent class analysis of functional somatic symptoms in a population-based sample of twins. Journal of Psychosomatic Research, 68, 5: 447-453. DOI: 10.1016/j.jpsychores.2010.01.010
  28. King S.A. (2013). The new Somatic Symptom Disorder in DSM-5 risks mislabeling many people as mentally ill. British Medical Journal, 346: f1580. DOI: 10.1136/bmj.f1580
  29. Kleinman A. (1988). The Illness Narratives. Suffering, Healing, and The Human Condition. New York: Basic Books.
  30. Kliem S., Beller J., Kröger C., Birowicz T., Zenger M. & Brähler E. (2014). Dimensional latent structure of somatic symptom reporting in two representative population studies: Results from taxometric analyses. Psychological Assessment, 26, 2: 484-492. DOI: 10.1037/a0035721
  31. Konnopka A., Schaefert R., Heinrich S., Kaufmann C., Luppa M., Herzog W. & König H.H. (2012). Economics of medically unexplained symptoms: a systematic review of the literature. Psychotherapy and Psychosomatics, 81, 5: 265-275. DOI: 10.1159/000337349
  32. Lacourt T., Houtveen J. & van Doornen L. (2013). “Functional somatic syndromes, one or many?” An answer by cluster analysis. Journal of Psychosomatic Research, 74, 1: 6-11. DOI: 10.1016/j.jpsychores.2012.09.013
  33. Lipowski Z.J. (1987). Somatization. American Journal of Psychiatry, 47: 160-167.
  34. Lipowski Z. (1989). Psychiatry: Mindless or brainless, both or neither? Canadian Journal of Psychiatry, 34: 249-254.
  35. Mayou R., Kirmayer L.J., Simon G., Kroenke K. & Sharpe M. (2005). Somatoform disorders: time for a new approach in DSM-V. American Journal of Psychiatry, 162, 5: 847-855. DOI: 10.1176/appi.ajp.162.5.847
  36. Migone P. (2006). La diagnosi in psicoanalisi: presentazione del PDM (Psychodynamic Diagnostic Manual). Psicoterapia e Scienze Umane, XL, 4: 765-774.
  37. Migone P. (2013). Presentazione del DSM-5. Psicoterapia e Scienze Umane, XLVII, 4: 567-600. DOI: 10.3280/PU2013-004001
  38. Nemiah J. C. (1984). The Psychodynamic View of Anxiety. In: Pasnau R.O., editor, Diagnosis and Treatment of Anxiety Disorders. Washington, D.C.: American Psychiatric Press, 1984, pp. 117-137.
  39. Pilowsky I. (1997). Abnormal Illness Behavior. Chichester, UK: Wiley.
  40. PDM Task Force (2006). Psychodynamic Diagnostic Manual (PDM). Silver Spring, MD: Alliance of Psychoanalytic Organizations. Vedi sito Internet: http://www.pdm1.org (trad. it.: PDM. Manuale Diagnostico Psicodinamico. Milano: Raffaello Cortina, 2008; trad. delle pp. 691-764 in: Psicoterapia e Scienze Umane, 2005, XXXIX, 1: 7-90). La seconda edizione (PDM-2), a cura di Robert S. Wallerstein (honorary chair) e Vittorio Lingiardi & Nancy McWilliams (co-chairs), è prevista per il 2015 presso l’editore Guilford di New York (trad. it.: Milano: Raffaello Cortina, 2015, in preparazione).
  41. Porcelli P. (2009). Medicina psicosomatica e psicologia clinica. Milano: Raffaello Cortina.
  42. Porcelli P. (2012). Sviluppi contemporanei della psicosomatica. Psicoterapia e Scienze Umane, XLVI, 3: 359-388. DOI: 10.3280/PU2012-003002
  43. Porcelli P. & De Carne M. (2008). Non-fearful panic disorder in gastroenterology. Psychosomatics, 49: 543-545. DOI: 10.1176/appi.psy.49.6.543
  44. Porcelli P., Fava G.A., Rafanelli C., Bellomo A., Grandi S., Grassi L., Pasquini P., Picardi A., Quartesan R., Rigatelli M. & Sonino N. (2012). Anniversary reactions in medical patients. Journal of Nervous and Mental Disease, 200, 7: 603-606. DOI: 10.1097/NMD.0b013e31825bfb2e
  45. Porcelli P. & Sonino N., a cura di (2008). Fattori psicologici che influenzano le malattie. Roma: Fioriti.
  46. Porcelli P. & Todarello O. (2003). La questione psicosomatica e il caso dell'ulcera peptica. Psicoterapia e Scienze Umane, XXXVII, 4: 57-91.
  47. Rief W., Mewes R., Martin A., Glaesmer H. & Brähler E. (2011). Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms. Psychosomatic Medicine, 73, 9: 760-768. DOI: 10.1097/PSY.0b013e318234eff6
  48. Simon G.E. & Gureje O. (1999). Stability of somatization disorder and somatization symptoms among primary care patients. Archives of General Psychiatry, 56, 1: 90-95. DOI: 10.1001/archpsyc.56.1.90
  49. Sirri L. & Fava G.A. (2013). Diagnostic Criteria for Psychosomatic Research and Somatic Symptom Disorders. International Review of Psychiatry, 25, 1: 19-30. DOI: 10.3109/09540261.2012.726923
  50. Sirri L., Fava G.A. & Sonino N. (2013). The unifying concept of illness behavior. Psychotherapy and Psychosomatics, 82, 2: 74-81. DOI: 10.1159/000343508
  51. Spitzer R.L. & Frances A. (2011). Guerre psicologiche: critiche alla preparazione del DSM-5. Psicoterapia e Scienze Umane, XLV, 2: 247-262. DOI: 10.3280/PU2011-002007
  52. Starcevic V. (2013). Hypochondriasis and health anxiety: Conceptual challenges. British Journal of Psychiatry, 202, 1: 7-8. DOI: 10.1192/bjp.bp.112.115402
  53. Stone J., Carson A., Duncan R., Coleman R., Roberts R., Warlow C., Hibberd C., Murray G., Cull R., Pelosi A., Cavanagh J., Matthews K., Goldbeck R., Smyth R., Walker J., Macmahon A.D. & Sharpe M. (2009). Symptoms “unexplained by organic disease” in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain, 132, 10: 2878-2788. DOI: 10.1093/brain/awp220
  54. Sykes R. (2012). The DSM-5 website proposals for Somatic Symptom Disorder: Three central problems. Psychosomatics, 53, 6: 524-531. DOI: 10.1016/j.psym.2012.06.004
  55. Szaz T. (1970). The Manufacture of Madness: A Comparative Study of the Inquisition and the Mental Health Movement. New York: Harper & Row; Syracuse, NY: Syracuse University Press, 1997 (trad. it.: I manipolatori della pazzia: studio comparato dell’Inquisizione e del movimento per la salute mentale in America. Milano: Feltrinelli, 1972).
  56. Taylor G.J. (2003). Somatization and conversion: Distinct or overlapping constructs? Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry, 31, 3: 487-508.
  57. Taylor G.J. (2010). Affects, trauma, and mechanisms of symptom formation: A tribute to John C. Nemiah, MD (1918-2009). Psychotherapy and Psychosomatics, 79, 6: 339-349. DOI: 10.1159/000320119
  58. Thomas M.L. & Locke D.E. (2010). Psychometric properties of the MMPI-2-RF Somatic Complaints (RC1) scale. Psychological Assessment, 22, 3: 492-503. DOI: 10.1037/a0019229
  59. Tinetti M.E. & Fried T. (2004). The end of the disease era. American Journal of Medicine, 116, 3: 179-185. DOI: 10.1016/j.amjmed.2003.09.031
  60. Voigt K., Wollburg E., Weinmann N., Herzog A., Meyer B., Langs G. & Löwe B. (2012). Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder – comparison with DSM-IV somatoform disorders and additional criteria for consideration. Journal of Psychosomatic Research, 73, 5: 345-350. DOI: 10.1016/j.jpsychores.2012.08.020
  61. Wakefield J.C. (2010). Misdiagnosing normality: Psychiatry’s failure to address the problem of false positive diagnoses of mental disorder in a changing professional environment. Journal of Mental Health, 19, 4: 337-351. DOI: 10.3109/09638237.2010.492418(trad.it.:Patologizzarelanormalità:l’incapacitàdellapsichiatriadiindividuareifalsipositivinellediagnosideidisturbimentali.PsicoterapiaeScienzeUmane,2010,XLIV,3:295-314.DOI:10.3280/PU2010-003001)
  62. Wessely S., Nimnuan C. & Sharpe M. (1999). Functional somatic syndromes: One or many? Lancet, 354, 9182: 936-939. DOI: 10.1016/S0140-6736(98)08320-2
  63. Wise T. (2014). Psychosomatics: Past, present and future. Psychotherapy and Psychosomatics, 83, 2: 65-69. DOI: 10.1159/000356518

Piero Porcelli, I disturbi di somatizzazione nel DSM-5 in "PSICOTERAPIA E SCIENZE UMANE" 3/2014, pp 431-452, DOI: 10.3280/PU2014-003004